Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors

키워드

참고문헌 (52)

1. Yao JC, "One hundred years after 'carcinoid':epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States", J Clin Oncol, 26, pp.3063~3072 (2008)
2. Modlin IM, "A 5-decade analysis of 13,715 carcinoid tumors", Cancer, 97, pp.934~959 (2003)
3. Modlin IM, "A 50-year analysis of 562 gastric carcinoids:small tumor or larger problem?", Am J Gastroenterol, 99, pp.23~32 (2004)
4. Dasari A, "Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States", JAMA Oncol, 3, pp.1335~1342 (2017)
5. Huang Q, "Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases", Am J Surg Pathol, 37, pp.467~483 (2013)
6. Lee CG, "The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.", BMC Cancer, 14, pp.569~ (2014)
7. Babu Kanakasetty G, "Clinicopathological profile of pure neuroendocrine neoplasms of the esophagus: a South Indian center experience", J Oncol, 2016, pp.2402417~ (2016)
8. Lv J, "Primary small cell carcinoma of the esophagus", J Thorac Oncol, 3, pp.1460~1465 (2008)
9. Bennouna J, "Small cell carcinoma of the esophagus: analysis of 10 cases and review of the published data", Am J Clin Oncol, 23, pp.455~459 (2000)
10. Ku GY, "Smallcell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience", Ann Oncol, 19, pp.533~537 (2008)
11. Kukar M, "Small cell carcinoma of the esophagus: a SEER database analysis", Ann Surg Oncol, 20, pp.4239~4244 (2013)
12. Vos B, "Small cell carcinoma of the esophagus: a multicentre rare cancer network study", Dis Esophagus, 24, pp.258~264 (2011)
13. Egashira A, "Neuroendocrine carcinoma of the esophagus: clinicopathological and immunohistochemical features of 14 cases", PLoS One, 12, pp.e0173501~ (2017)
14. Deng HY, "Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection", J Thorac Dis, 8, pp.1250~1256 (2016)
15. Wong AT, "Treatment and survival outcomes of small cell carcinoma of the esophagus:an analysis of the national cancer data base", Dis Esophagus, 30, pp.1~5 (2017)
16. Rindi G, "Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma:a clinicopathologic study", Gastroenterology, 104, pp.994~1006 (1993)
17. O’Toole D, "Gastric and duodenal neuroendocrine tumours", Best Pract Res Clin Gastroenterol, 26, pp.719~735 (2012)
18. Delle Fave G, "ENETS consensus guidelines for the management of patients with gastroduodenal neoplasms", Neuroendocrinology, 95, pp.74~87 (2012)
19. Delle Fave G, "ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms", Neuroendocrinology, 103, pp.119~124 (2016)
20. Niederle MB, "Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European neuroendocrine tumour society classification:an analysis based on prospectively collected parameters", Endocr Relat Cancer, 17, pp.909~918 (2010)
21. Tsai HJ, "The epidemiology of neuroendocrine tumors in Taiwan: a nation-wide cancer registry-based study", PLoS One, 8, pp.e62487~ (2013)
22. Hallet J, "Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes", Cancer, 121, pp.589~597 (2015)
23. Pavel M, "ENETS consensus guidelines for the standard of care in neuroendocrine tumors", Neuroendocrinology, 105, pp.193~195 (2017)
24. Sundin A, "ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging", Neuroendocrinology, 105, pp.212~244 (2017)
25. Campana D, "Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study", Endocrine, 56, pp.633~638 (2017)
26. Roy PK, "Zollinger-Ellison syndrome. Clinical presentation in 261 patients", Medicine (Baltimore), 79, pp.379~411 (2000)
27. O’Toole D, "Endoscopy and endoscopic ultrasound in assessing and managing neuroendocrine neoplasms", Front Horm Res, 44, pp.88~103 (2015)
28. Rindi G, "WHO classification of tumours of the digestive system", pp.13~ (2010), International Agency for Research on Cancer (IARC)
29. Schindl M, "Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment", Arch Surg, 136, pp.49~54 (2001)
30. Borch K, "Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type", Ann Surg, 242, pp.64~73 (2005)
31. Yo Han Park, "Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer", 대한암예방학회지, 20(1), pp.25~40 (2015), 대한암예방학회[DOI]
32. O’Connor A, "Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer", Cochrane Database Syst Rev, pp.CD009322~ (2013)
33. Kunz PL, "Consensus guidelines for the management and treatment of neuroendocrine tumors", Pancreas, 42, pp.557~577 (2013)
34. Merola E, "Type I gastric carcinoids:a prospective study on endoscopic management and recurrence rate", Neuroendocrinology, 95, pp.207~213 (2012)
35. Li QL, "Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study", World J Gastroenterol, 18, pp.5799~5806 (2012)
36. Sato Y, "Usefulness of endoscopic submucosal dissection for type I gastric carcinoid tumors compared with endoscopic mucosal resection", Hepatogastroenterology, 60, pp.1524~1529 (2013)
37. Kim HH, "The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection", Gastroenterol Res Pract 2014, pp.253860~ (2014)
38. Campana D, "Gastric endocrine tumors type I:treatment with long-acting somatostatin analogs", Endocr Relat Cancer, 15, pp.337~342 (2008)
39. Jianu CS, "Fiveyear follow-up of patients treated for 1 year with octreotide long-acting release for enterochromaffin-like cell carcinoids", Scand J Gastroenterol, 46, pp.456~463 (2011)
40. Klöppel G, "The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification", Ann N Y Acad Sci, 1014, pp.13~27 (2004)
41. Okubo Y, "Duodenal rare neuroendocrine tumor: clinicopathological characteristics of patients with gangliocytic paraganglioma", Gastroenterol Res Pract 2016, pp.5257312~ (2016)
42. Hoffmann KM, "Duodenal neuroendocrine tumors: classification, functional syndromes, diagnosis and medical treatment", Best Pract Res Clin Gastroenterol, 19, pp.675~697 (2005)
43. Stamm B, "Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN I syndrome and von Recklinghausen’s disease (neurofibromatosis)", Virchows Arch A Pathol Anat Histopathol, 408, pp.475~489 (1986)
44. Benya RV, "Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I", Am J Med, 97, pp.436~444 (1994)
45. Gibril F, "Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature", Medicine (Baltimore), 83, pp.43~83 (2004)
46. Yu F, "Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome", J Clin Oncol, 17, pp.615~630 (1999)
47. Weber HC, "Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study", Gastroenterology, 108, pp.1637~1649 (1995)
48. Thakker RV, "Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)", J Clin Endocrinol Metab, 97, pp.2990~3011 (2012)
49. Dalenbäck J, "Local endoscopic removal of duodenal carcinoid tumors", Endoscopy, 36, pp.651~655 (2004)
50. Kim GH, "Endoscopic resection for duodenal carcinoid tumors: a multicenter, retrospective study", J Gastroenterol Hepatol, 29, pp.318~324 (2014)
51. Matsumoto S, "Duodenal carcinoid tumors: 5 cases treated by endoscopic submucosal dissection", Gastrointest Endosc, 74, pp.1152~1156 (2011)
52. Suzuki S, "Endoscopic submucosal dissection (ESD) for gastrointestinal carcinoid tumors", Surg Endosc, 26, pp.759~763 (2012)

관련 논문AI추천